30
/it/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
April 1, 2024
5819793
551854
1

9 nov 2020 anni - The FDA grants an EUA for Eli Lilly’s monoclonal antibody treatment, bamlanivimab. Lilly showed that hospitalizations in COVID-19 patients decreased within 28 days, indicating that it prevents severe forms of the disease when administered quickly.

Aggiunto al nastro di tempo:

Data:

9 nov 2020 anni
Adesso
~ 3 years and 6 months ago